Oragenics OGEN
NYSE OGEN
$0.41 -0.01 (-3.26%)
As of: Oct 21, 2026 · 2:54 PM EDT

Oragenics (OGEN) Divestments (2016)

Updated

Oragenics' Divestments came in at $200,000 for Q4 2016.

Analysis

Oragenics (OGEN) Divestments (2016) Analysis & Trends

For FY2016, Oragenics' Divestments was $1.45 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,136.82 Bn 1,105.41 Bn 19.71 Bn -
2 Johnson & Johnson 617.41 Bn 535.94 Bn 17.26 Bn -
3 AbbVie 501.29 Bn 474.40 Bn 12.70 Bn -
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn -
5 Novartis Ag 297.07 Bn 261.06 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn -
7 Amgen 236.34 Bn 191.74 Bn 7.24 Bn -
8 Gilead Sciences 191.00 Bn 165.20 Bn 6.22 Bn -
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn -
10 Oragenics 1.83 Mn -27.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 200,000.00
API Access

Oragenics Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=OGEN&period=max&api_key=YOUR_API_KEY